Prestige Wealth Management Group’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.59K | Buy |
9
+1
| +13% | +$287 | ﹤0.01% | 686 |
|
|
2025
Q1 | $2.47K | Hold |
8
| – | – | ﹤0.01% | 698 |
|
|
2024
Q4 | $2.82K | Hold |
8
| – | – | ﹤0.01% | 711 |
|
|
2024
Q3 | $2.87K | Hold |
8
| – | – | ﹤0.01% | 703 |
|
|
2024
Q2 | $2.55K | Buy |
8
+1
| +14% | +$319 | ﹤0.01% | 674 |
|
|
2024
Q1 | $1.61K | Sell |
7
-22
| -76% | -$5.06K | ﹤0.01% | 789 |
|
|
2023
Q4 | $6.38K | Hold |
29
| – | – | ﹤0.01% | 538 |
|
|
2023
Q3 | $6.55K | Hold |
29
| – | – | ﹤0.01% | 516 |
|
|
2023
Q2 | $6.4K | Buy |
29
+26
| +867% | +$5.74K | ﹤0.01% | 529 |
|
|
2023
Q1 | $672 | Hold |
3
| – | – | ﹤0.01% | 937 |
|
|
2022
Q4 | $834 | Hold |
3
| – | – | ﹤0.01% | 1000 |
|
|
2022
Q3 | $1K | Hold |
3
| – | – | ﹤0.01% | 931 |
|
|
2022
Q2 | $1K | Hold |
3
| – | – | ﹤0.01% | 936 |
|
|
2022
Q1 | $1K | Hold |
3
| – | – | ﹤0.01% | 941 |
|
|
2021
Q4 | $1K | Hold |
3
| – | – | ﹤0.01% | 960 |
|
|
2021
Q3 | $1K | Hold |
3
| – | – | ﹤0.01% | 945 |
|
|
2021
Q2 | $1K | Hold |
3
| – | – | ﹤0.01% | 935 |
|
|
2021
Q1 | $1K | Hold |
3
| – | – | ﹤0.01% | 920 |
|
|
2020
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 1043 |
|
|
2020
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 924 |
|
|
2020
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 963 |
|
|
2020
Q1 | $0 | Buy |
+3
| New | – | ﹤0.01% | 1010 |
|
|
2019
Q3 | – | Sell |
-3,058
| Closed | -$238K | – | 645 |
|
|
2019
Q2 | $238K | Sell |
3,058
-2,103
| -41% | -$164K | 0.14% | 102 |
|
|
2019
Q1 | $606K | Buy |
5,161
+1,218
| +31% | +$143K | 0.37% | 48 |
|
|
2018
Q4 | $429K | Buy |
+3,943
| New | +$429K | 0.32% | 62 |
|